• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-erbB-2癌基因与乳腺癌中p53表达、细胞增殖及预后的关系

c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.

作者信息

Lipponen H J, Aaltomaa S, Syrjänen S, Syrjänen K

机构信息

Department of Pathology, University of Kuopio, Finland.

出版信息

Anticancer Res. 1993 Jul-Aug;13(4):1147-52.

PMID:8102517
Abstract

A series of 193 archival breast cancer biopsies were analysed immunohistochemically to detect over-expression of c-erbB-2 oncoprotein. Altogether, 59/193 (31%) of the tumours were positive for c-erbB-2, the staining being located at the cell membranes with weak cytoplasmic staining in some samples. The expression of c-erbB-2 was positively correlated with a number of parameters analysed: ductal type, intraductal growth pattern, high tumour grade, density of tumour infiltrating lymphocytes (TIL), DNA aneuploidy, steroid (ER, PR) receptor negativity, high S-phase fraction, high mitotic frequency, high values of nuclear factors, and accumulation of p53 protein. c-erbB-2 expression showed a weak association with a low survival probability (p = 0.07) and with a short recurrence-free survival (p = 0.1). In local tumours or in axillary lymph node positive tumours, c-erB-2 expression had no significant prognostic value. Also in multivariate analysis, c-erbB-2 expression had no independent prognostic value superior to the axillary lymph node status, tumour diameter and mitotic frequency. The results show that c-erbB-2 expression in related to several histopathological features of malignancy and cell proliferation in breast cancer, but it has no independent prognostic value better than that of the established prognostic factors.

摘要

对193份存档的乳腺癌活检样本进行免疫组织化学分析,以检测c-erbB-2癌蛋白的过表达情况。总共193例肿瘤中有59例(31%)c-erbB-2呈阳性,染色位于细胞膜,部分样本细胞质染色较弱。c-erbB-2的表达与所分析的一些参数呈正相关:导管类型、导管内生长模式、高肿瘤分级、肿瘤浸润淋巴细胞(TIL)密度、DNA非整倍体、类固醇(ER、PR)受体阴性、高S期分数、高有丝分裂频率、高核因子值以及p53蛋白的积累。c-erbB-2表达与低生存率(p = 0.07)和短无复发生存期(p = 0.1)呈弱相关。在局部肿瘤或腋窝淋巴结阳性肿瘤中,c-erB-2表达无显著预后价值。在多因素分析中,c-erbB-2表达也没有优于腋窝淋巴结状态、肿瘤直径和有丝分裂频率的独立预后价值。结果表明,c-erbB-2表达与乳腺癌的几种恶性组织病理学特征和细胞增殖相关,但它没有比既定预后因素更好的独立预后价值。

相似文献

1
c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.c-erbB-2癌基因与乳腺癌中p53表达、细胞增殖及预后的关系
Anticancer Res. 1993 Jul-Aug;13(4):1147-52.
2
Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer.
J Pathol. 1994 Oct;174(2):101-9. doi: 10.1002/path.1711740206.
3
Expression of p53 protein has no independent prognostic value in breast cancer.p53蛋白的表达在乳腺癌中无独立预后价值。
J Pathol. 1995 Nov;177(3):225-32. doi: 10.1002/path.1711770303.
4
Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.免疫组织化学检测c-erbB-2原癌基因表达及核DNA含量在人类乳腺癌中的预后意义
Eur J Surg Oncol. 1992 Dec;18(6):530-7.
5
Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.对DNA倍体、p53、c-erbB-2蛋白、表皮生长因子受体(EGFR)和类固醇激素受体进行多变量分析,以预测乳腺癌短期预后不良。
Anticancer Res. 1997 Mar-Apr;17(2B):1417-23.
6
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.356例腋窝淋巴结阴性乳腺癌中p53、c-erbB-2、拓扑异构酶IIα表达、DNA倍体、激素受体状态及增殖之间的相关性:预后意义
J Pathol. 1999 Jan;187(2):207-16. doi: 10.1002/(SICI)1096-9896(199901)187:2<207::AID-PATH223>3.0.CO;2-U.
7
Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.p53与c-erbB-2蛋白共表达在乳腺癌中的预后意义
J Pathol. 1996 May;179(1):31-8. doi: 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O.
8
Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.c-erbB-2和雌激素受体状态在人类乳腺癌中的预后意义。
Cancer Res. 1991 Jun 15;51(12):3296-303.
9
Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.c-erbB-2基因扩增与淋巴结阴性乳腺癌疾病复发风险之间的相关性。
Cancer Res. 1991 Jan 15;51(2):556-67.
10
Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.DNA倍体、p53、c-erbB-2蛋白、表皮生长因子受体(EGFR)及类固醇激素受体对乳腺癌短期预后的多因素分析
Anticancer Res. 1997 Jul-Aug;17(4B):3091-7.

引用本文的文献

1
Status of epidermal growth factor receptors family in hormone-dependent carcinomas of the breast and prostate with reference to serum lipids and lipoproteins.表皮生长因子受体家族在乳腺和前列腺激素依赖性癌中的状况与血清脂质和脂蛋白的关系
Indian J Clin Biochem. 2001 Jan;16(1):42-51. doi: 10.1007/BF02867567.
2
Biological indices in the assessment of breast cancer.评估乳腺癌的生物学指标。
Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221.
3
Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.
由ErbB2介导的信号转导复杂性:受体靶向癌症治疗潜力的线索
Pathol Oncol Res. 1999;5(4):255-71. doi: 10.1053/paor.1999.0255.
4
c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.通过自动定量免疫细胞化学检测乳腺癌中的c-erbB-2癌蛋白与患者的总生存期和无病生存期相关。
Br J Cancer. 1997;75(11):1667-73. doi: 10.1038/bjc.1997.283.
5
Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients.HER-2/neu与p53的共表达与淋巴结阳性乳腺癌患者较短的无病生存期相关。
J Cancer Res Clin Oncol. 1994;120(12):737-42. doi: 10.1007/BF01194273.